LYT-210

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameLYT-210
Drug Alias NameLYT-210
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAntibody-dependent cell-mediated cytotoxicity (ADCC) effectsT lymphocytes stimulantsPhagocytes stimulants
TargetsNot applicable
Therapy Area/IndicationsSolid tumoursAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPuretech Health
China Registration ClassN/A

Develop Information

Active CompaniesPuretech Health
Inactive CompaniesN/A
Active IndicationsSolid tumoursAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A